Differences in hospice care between home and institutional settings.

Differences in hospice care between home and institutional settings. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Differences in hospice care between home and institutional settings. Abstract Text:

David G Stevenson,Haiden A Huskamp,David C Grabowski,Nancy L Keating,David G Stevenson,Haiden A Huskamp,David C Grabowski,Nancy L Keating,

OBJECTIVE: To compare hospice care delivered at home with hospice care delivered in institutional settings, such as the nursing home. DATA SOURCE: Secondary data from the 1994, 1996, 1998, and 2000 waves of the National Home and Hospice Care Survey, a nationally representative survey of home health and hospice care agencies in the United States and their current and discharged patients. STUDY DESIGN: We describe recipients, use of services, and length of enrollment for hospice received at home compared to hospice received in institutional settings. Comparisons of service use and lengths of enrollment are adjusted for age, gender, race/ethnicity, location, Charlson score, payer status, and linear time trends. PRINCIPAL FINDINGS: Hospice use in the United States has grown considerably over the last decade, especially among individuals in institutional settings. Institutional hospice users were older than home hospice users; more likely to be female, unmarried, and dually eligible for Medicare and Medicaid; and more likely to have primary diagnoses other than cancer. Although institutional hospice users were more likely to have received certain types of services compared to recipients at home, they were much more likely to be enrolled for 1 week or less. CONCLUSIONS: These national data point to significant differences across hospice settings and a growing need to analyze their implications. Yet, these data also leave many questions about hospice use across settings unanswered, including whether agency costs differ in institutional compared to home settings. As policymakers seek to assess the quality and appropriateness of hospice utilization and the methods used for its payment, further empirical work is needed, including how the growing use of hospice outside the home affects options for reform.

Differences in hospice care between home and institutional settings. Publishing Authors By Initials

DG Stevenson,HA Huskamp,DC Grabowski,NL Keating,DG Stevenson,HA Huskamp,DC Grabowski,NL Keating,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Differences in hospice care between home and institutional settings. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of palliative medicine

VOLUME: 10

Page Numbers: 1040-7

Journal Abbreviation:

ISSN: 1096-6218

DAY: 7

MONTH: Oct

YEAR: 2007

Differences in hospice care between home and institutional settings. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9808462

Differences in hospice care between home and institutional settings. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Differences in hospice care between home and institutional settings. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Differences in hospice care between home and institutional settings.

AFFILIATION: Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA. stevenson@hcp.med.harvard.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Palliat Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Differences in hospice care between home and institutional settings Related Publications

• Activin-betaA signaling is required for zebrafish fin regeneration.
• Campuses of the LACC.
• Celecoxib : a review of its use in the management of arthritis and acute pain.
• Clinical and pharmacokinetic study of clofarabine in chronic lymphocytic leukemia: strategy for treatment.
• Colesevelam: a review of its use in hypercholesterolemia.
• Computing van der Waals energies in the context of the rotamer approximation.
• Coupling molecular beacons to barcoded metal nanowires for multiplexed, sealed chamber DNA bioassays.
• Coverage and prior authorization of psychotropic drugs under Medicare Part D.
• Deferasirox : a review of its use in the management of transfusional chronic iron overload.
• Differences in hospice care between home and institutional settings.
• Distance-dependent emission from dye-labeled oligonucleotides on striped Au/Ag nanowires: effect of secondary structure and hybridization efficiency.
• Dr. Tom Lawrence: a life in chiropractic.
• E14 Therapy for CLL: current approach, future trends.
• Gene expression analysis of zebrafish heart regeneration.
• Maraviroc.
• Metallic barcodes for multiplexed bioassays.
• Methods for simulating the dynamics of complex biological processes.
• Modeling backbone flexibility to achieve sequence diversity: the design of novel alpha-helical ligands for Bcl-xL.
• Monoclonal antibodies in chronic lymphocytic leukemia.
• On-beam synchrony in the cerebellum as the mechanism for the timing and coordination of movement.
• One size doesn't fit all.
• Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair.
• Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness.
• Revision anterior cruciate ligament reconstruction: timing of surgery and the incidence of meniscal tears and degenerative change.
• Rivastigmine transdermal patch: in the treatment of dementia of the Alzheimer's type.
• Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease.
• Silica-coated, Au/Ag striped nanowires for bioanalysis.
• The Homewood influence in Canada and beyond.
• Transcriptional profiling of caudal fin regeneration in zebrafish.
• Using performance data to identify preferred hospitals.